5th Annual Extractables & Leachables Summit 2025 is organized by Uventia Global s.r.o. and will be held from Feb 27 - 28, 2025.
Overview:
The assessment of extractables and leachables is a critical step in the biopharmaceutical development process. The interactions between pharmaceutical products and drug delivery systems, bioprocess manufacturing systems, and container closing systems are of special concern for regulatory bodies. Therefore, it is necessary to carefully examine the migration of mobile molecules from the materials and components utilized in the production and storage of pharmaceuticals.
We organize a virtual conference to facilitate discussion on the most recent analytical techniques, regulatory updates, risk-based E&L programs, chemical characterization and toxicological risk assessment among scientists, toxicologists and E&L managers. We also cover ISO 10993-18, medical device materials, analytical and safety thresholds and customized systems for different product types.
Participate in our event to learn about the latest methods for testing and analyzing extractables and leachables. This can help you significantly reduce the risks associated with E&L while also assuring patient safety and product quality.
We Will Talk About:
• Sample preparation, extraction studies and quantification.
• Classifying and identifying targeted substances.
• Risk assessment and profiling for extractables.
• Assessment of stability studies and leachables.
• Introduction: why do we need to care about E&L?
• How to perform a Toxicological Risk Assessment.
• The concept of Permitted Daily Exposure (PDE).
• The concept of Threshold of Toxicological Concern (TTC).
• Compounds of specific concern: Nitrosamines.
• Introduction to general safety and regulatory considerations for extractables/
leachables (E&Ls) in pharmaceutical products.
• Considerations for different administration routes, including (topical) ocular.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved